CHOLESTEROL CAN BE LOWERED IN OLDER PERSONS - SHOULD WE CARE

被引:20
作者
KAISER, FE [1 ]
MORLEY, JE [1 ]
机构
[1] ST LOUIS VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,ST LOUIS,MO
关键词
D O I
10.1111/j.1532-5415.1990.tb01604.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:84 / 85
页数:2
相关论文
共 21 条
[1]  
AGNER E, 1983, ACTA MED SCAND, V214, P33
[2]   CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY [J].
ANDERSON, KM ;
CASTELLI, WP ;
LEVY, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2176-2180
[3]   THE USE OF SIMVASTATIN, AN HMG COA REDUCTASE INHIBITOR, IN OLDER PATIENTS WITH HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS [J].
BACH, LA ;
COOPER, ME ;
OBRIEN, RC ;
JERUMS, G .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (01) :10-14
[4]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[5]  
EDERER F, 1971, LANCET, V2, P203
[6]  
FLOOD JF, 1990, IN PRESS GERIATRIC N
[7]  
FORETTE B, 1989, LANCET, V1, P868
[8]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[9]  
FRIES JF, 1989, LANCET, V1, P481
[10]   PLASMA-CHOLESTEROL, CORONARY HEART-DISEASE, AND CANCER IN THE RENFREW AND PAISLEY SURVEY [J].
ISLES, CG ;
HOLE, DJ ;
GILLIS, CR ;
HAWTHORNE, VM ;
LEVER, AF .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6678) :920-924